Liu Jian, Xu Tianmin, Ma Li, Chang Weiqin
Department of Gynaecology and Obstetrics, Jilin University Second Hospital, Changchun, China.
Department of Thyroid Surgery, Jilin University Second Hospital, Changchun, China.
Front Oncol. 2021 Apr 28;11:593479. doi: 10.3389/fonc.2021.593479. eCollection 2021.
The molecular mechanisms underlying the development of thyroid cancer (TC) have been examined through extensive experiments. A large number of studies have shown that the incidences of thyroid cancer in women is much higher than that in men, so estrogen plays a key role in the development of thyroid cancer. Estrogen plays its growth-promoting role through classical genomic and non-genomic pathways mediated by membrane-bound estrogen receptors. It also can affect tumor progression by regulating the tumor microenvironment. We summarize the understanding of molecular mechanisms of estrogen signaling pathways in thyroid cancer. Furthermore, it will provide a new target for the treatment of thyroid carcinoma by blocking estrogen and its related action pathway.
通过广泛的实验研究了甲状腺癌(TC)发生发展的分子机制。大量研究表明,女性甲状腺癌的发病率远高于男性,因此雌激素在甲状腺癌的发生发展中起关键作用。雌激素通过由膜结合雌激素受体介导的经典基因组和非基因组途径发挥其促生长作用。它还可通过调节肿瘤微环境影响肿瘤进展。我们总结了对甲状腺癌中雌激素信号通路分子机制的认识。此外,通过阻断雌激素及其相关作用途径,将为甲状腺癌的治疗提供新的靶点。
Front Oncol. 2021-4-28
Endocr Relat Cancer. 2014-10
J Clin Endocrinol Metab. 2001-3
Expert Rev Endocrinol Metab. 2011-3
NPJ Womens Health. 2025
J Transl Med. 2025-1-24
Int J Mol Sci. 2021-2-6
Int J Mol Sci. 2019-9-7
Oxid Med Cell Longev. 2019-1-9